Entasis Therapeutics

Developer of a portfolio of cures for serious drug-resistant bacterial infections

placeWaltham, Massachusetts, United States calendar_todayFounded 2015 groups40 employees language entasistx.com

Registered entities

Innovation

19 patent families (8 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 597 times.

YearFilings
20154
20165
20175
20187
20196
20206
20217
20225
20236
20245
20259
20263

Investor mix

10 investors on record.

Investor typeCountShare
Venture capital220%
Private equity330%
Other / undisclosed550%
Coming soon